QGEN Qiagen PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: QGEN
- PE Ratio
As of Aug 8, 2025, the QGEN stock has a PE ratio of 28.26. The calculation is based on the latest EPS of $1.7 and the stock price of $48.04 per share. A decrease of 68% has been observed in the PE ratio compared to its average of 88.2 of the last four quarters.
QGEN PE ratio history
The mean historical PE ratio of Qiagen over the last ten years is 81.84. The current 28.26 P/E ratio is 65% lower than the historical average. Looking back at the last ten years, QGEN's PE ratio peaked in the Jun 2020 quarter at 882.68, with a price of $44.13 and an EPS of $0.05. The Sep 2021 quarter marked the lowest point at 19.81, with a price of $53.28 and an EPS of $2.69.
Qiagen PE ratio by year
Maximum annual increase: 292.56% in 2024
Maximum annual decrease: -75.68% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 117.18 | 292.56% | $44.53 | $0.38 |
| 2023 | 29.85 | 8% | $44.77 | $1.5 |
| 2022 | 27.64 | 8.52% | $51.41 | $1.86 |
| 2021 | 25.47 | -24.26% | $57.3 | $2.25 |
| 2020 | 33.63 | N/A | $54.49 | $1.62 |
| 2019 | N/A | N/A | $34.85 | -$0.19 |
| 2018 | 40.82 | -75.68% | $35.52 | $0.87 |
| 2017 | 167.83 | 95.81% | $31.89 | $0.19 |
| 2016 | 85.71 | 67.93% | $30 | $0.35 |
| 2015 | 51.04 | 5.67% | $29.6 | $0.58 |
| 2014 | 48.3 | -39.37% | $25.12 | $0.52 |
| 2013 | 79.66 | 141.91% | $25.49 | $0.32 |
| 2012 | 32.93 | -1.99% | $19.43 | $0.59 |
| 2011 | 33.6 | 5.96% | $14.79 | $0.44 |
| 2010 | 31.71 | -4.49% | $20.93 | $0.66 |
Qiagen PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 28.27 | -69.72% | $48.06 | $1.7 |
| Mar 2025 | 93.37 | -20.32% | $40.15 | $0.43 |
| Dec 2024 | 117.18 | 2.85% | $44.53 | $0.38 |
| Sep 2024 | 113.93 | -16.82% | $45.57 | $0.4 |
| Jun 2024 | 136.97 | 371.5% | $41.09 | $0.3 |
| Mar 2024 | 29.05 | -2.68% | $42.99 | $1.48 |
| Dec 2023 | 29.85 | 0.81% | $44.77 | $1.5 |
| Sep 2023 | 29.61 | -8.16% | $41.75 | $1.41 |
| Jun 2023 | 32.24 | 3.5% | $46.42 | $1.44 |
| Mar 2023 | 31.15 | 12.7% | $47.35 | $1.52 |
| Dec 2022 | 27.64 | 31.18% | $51.41 | $1.86 |
| Sep 2022 | 21.07 | -2.59% | $42.56 | $2.02 |
| Jun 2022 | 21.63 | 1.07% | $48.66 | $2.25 |
| Mar 2022 | 21.4 | -15.98% | $50.52 | $2.36 |
| Dec 2021 | 25.47 | 28.57% | $57.3 | $2.25 |
QGEN Price vs fair value
QGEN average PE ratio chart
The current PE ratio of QGEN is lower than its 3, 5 and 10-year averages.
QGEN PE vs peers
QGEN's PE ratio stands lower than its peer stocks GE and BDX, but it is higher than TMO's and HOLX's. Qiagen's current PE ratio of 28.26 is lower than the average of its peers, which is 37.72.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TMO Thermo Fisher Scientific Inc | 26.6 | $173.97B |
| HOLX Hologic Inc | 28.01 | $15.14B |
| QGEN Qiagen NV | 28.26 | $10.46B |
| BDX Becton Dickinson & Co | 35.18 | $55.46B |
| GE General Electric Co | 38.04 | $291.63B |
| TECH BIO-TECHNE Corp | 60.75 | $7.9B |
Frequently asked questions
What is Qiagen's PE ratio?
The price to earnings ratio for QGEN stock is 28.26 as of Aug 8, 2025.
What is the 3-year average PE ratio for Qiagen (QGEN)?
The average PE ratio for QGEN stock over the past 3 years is 57.53.
What is the 5-year average PE ratio for Qiagen (QGEN)?
The average PE ratio for QGEN stock over the past 5 years is 46.09.
What is the highest PE ratio for QGEN?
The highest quarterly PE ratio in the last ten years has been 882.68 and it was in the Jun 2020 quarter.
How does the current PE ratio for QGEN compare to its historical average?
QGEN's current price to earnings ratio is 65% below its 10-year historical average.
How is QGEN's PE ratio calculated (Qiagen PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Aug 8, 2025), Qiagen's share price is $48.04. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $1.7. Therefore, Qiagen's PE ratio for today is 28.26. PE RATIO(28.26) = STOCK PRICE($48.04) / TTM EPS($1.7)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.